Med-tech giant Medtronic (Minneapolis) said Monday it will pay up to $500 million to acquire Invatec (Brescia, Italy), developer of devices for the interventional treatment of cardiovascular disease, and two affiliated companies, Fogazzi (also Brescia), which provides polymer technology to Invatec; and Krauth Cardiovascular (Hamburg, Germany), which distributes Invatec products in Germany. (Medical Device Daily)